We follow the ICH GCP Guidelines, the Clinical Trial Regulation (EU) No 536/2014 and other relevant guidelines and are GCP certified by ANVISA
In addition, a number of drugs are being developed that target both the GIP and GLP-1 pathways, and triple-agonists at the glucagon, GIP, and GLP-1 receptors
As with all health and wellbeing products, its of the utmost importance that supplement innovators in this fast-moving health area prioritise solid science and high-quality ingredients to ensure such products are reliable and can deliver the benefits consumers are looking for
Do not inject the product more than your doctor prescribes
Healthcare professionals should educate patients about the symptoms of acute pancreatitis and advise them to seek urgent care if they experience severe pain
These symptoms can escalate to life-threatening difficulties for individuals with comorbidities such as type II diabetes, frailty, heart disease and general aging